Where does Richard Heyman work?

Richard Heyman is Founder of Architect Therapeutics and Venture Partner at ARCH Venture Partners.

What check size does Richard Heyman write?

Richard Heyman typically writes checks of $50K – $150M.

What companies did Richard Heyman found?

Richard Heyman founded Architect Therapeutics.

What boards does Richard Heyman sit on?

Richard Heyman holds tracked board seats at Enliven Therapeutics, Metacrine, Vividion Therapeutics.

Where did Richard Heyman go to school?

Richard Heyman studied at University of Minnesota (PhD, Pharmacology).

Richard Heyman

InvestorFounder

Venture Partner at ARCH Venture Partners

Encinitas, California

Writes $50K – $150M checks · typically $25M

FoundedArchitect Therapeutics

Likely email· guessed from name + firm domain, not firm-published

r•••@archventure.comreveal100% confident

Experience

Pelage PharmaceuticalsBoard Membercurrent2025 — present
Architect TherapeuticsChairman of the BOD and Co-Foundercurrent2023 — present
ORIC PharmaceuticalsChairman of the BODcurrent2014 — presentSouth San Francisco
Enliven TherapeuticsBOD Member/Chairmancurrent2020 — present
Vividion Therapeutics, Inc.BOD member/Former Chairmancurrent2018 — present
PMV Pharmaceuticals, Inc.Chairman of the Boardcurrent2020 — present
ARCH Venture PartnersVenture Partnercurrent2020 — present
Nextech InvestScience Partnercurrent2022 — present
Salk Institute for Biological StudiesMember Board of Trusteescurrent2015 — presentLa Jolla, CA
CureboundBoard Member and Scientific Advisory Board Membercurrent2021 — present
Life Science Cares San DiegoBoard of Managerscurrent2020 — present
RayzeBioChairman of the Board2022 — 2023
Metacrine Inc.Executive Chairman2015 — 2022San Diego
Amunix PharmaceuticalsChairperson of the Board2019 — 2021
Yumanity TherapeuticsBOD Member2016 — 2021Cambridge, Ma
Gritstone OncologyBOD Member2015 — 2021Emeryville, CA
Seragon PharmaceuticalsPresident and CEO2013 — 2015
Aragon PharmaceuticalsPresident and CEO2009 — 2013
Kalypsys, Inc.Chief Scientific Officer2006 — 2008
Exelixis, Inc.Sr. Vice President2004 — 2006
X-Ceptor TherapeuticsCSO1999 — 2006
Ligand PharmaceuticalsVP Research1990 — 1999
Salk InstitutePostdoctoral Fellow1986 — 1990

Skills & more

Drug Discovery99Biotechnology79Lifesciences25Molecular Biology28Biochemistry24Pharmacology51Clinical Development38Drug Development82Cell Culture18Oncology30Pharmaceutical Industry51Cell Biology21

+3 more

In VitroAssay DevelopmentIn Vivo

From Richard's professional profile.

Deals · 3

Enliven TherapeuticsBoard seat

via ARCH Venture Partners · filed Apr 2024 · $90M raise

Vividion TherapeuticsBoard seat

via ARCH Venture Partners · filed May 2019 · $82M raise

MetacrineBoard seat

via ARCH Venture Partners · filed Nov 2016 · $37.8M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at ARCH Venture Partners

Ari Nowacek

Partner at ARCH Venture Partners

Ari Nowacek, M.D, Ph.D.

Partner at ARCH Venture Partners

Axel Bouchon

Venture Partner at ARCH Venture Partners

Axel Bouchon, Ph.D.

Venture Partner at ARCH Venture Partners

Brian Cuneo

Senior Partner at ARCH Venture Partners

Carol Suh

Partner at ARCH Venture Partners

Clinton Bybee

Co-founder & Managing Director, Emeritus at ARCH Venture Partners

Corey Ritter

Partner at ARCH Venture Partners

Frequently asked questions

Who is Richard Heyman?: Venture Partner at ARCH Venture Partners
Where does Richard Heyman work?: Richard Heyman is Founder of Architect Therapeutics and Venture Partner at ARCH Venture Partners.
What check size does Richard Heyman write?: Richard Heyman typically writes checks of $50K – $150M.
What companies did Richard Heyman found?: Richard Heyman founded Architect Therapeutics.
What boards does Richard Heyman sit on?: Richard Heyman holds tracked board seats at Enliven Therapeutics, Metacrine, Vividion Therapeutics.
Where did Richard Heyman go to school?: Richard Heyman studied at University of Minnesota (PhD, Pharmacology).